Inhibition of activation of the classical pathway of complement by human neutrophil defensins

Blood

Volumn 92, Issue 10, 1998, Pages 3898-3903

  Van den Berg, Rocco H ^a   Faber Krol, Maria C ^a   Van Wetering, Sandra ^a   Hiemstra, Pieter S ^a   Daha, Mohamed R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COMPLEMENT COMPONENT C1Q; DEFENSIN;

AMINO ACID SEQUENCE; ARTICLE; CELL ISOLATION; COMPLEMENT ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMOLYSIS; HUMAN; HUMAN CELL; INFLAMMATION; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION;

EID: 0032533889     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.10.3898.422k03_3898_3903     Document Type: Article

References (41)

1. Rice WG, Ganz T, Kinkade JMJ, Selsted ME, Lehrer RI, Parmley RT: Defensin-rich granules of human neutrophils. Blood 70:757, 1987
2. Mallow EB, Harris A, Salzman N, Russell JP, DeBerardinis RJ, Ruchelli E, Bevins CL: Human enteric defensins. Gene structure and developmental expression. J Biol Chem 271:4038, 1996
3. Zhao C, Wang L, Lehrer RI: Widespread expression of beta defensin hBD1 in human secretory glands and epithelial cells. FEBS Lett 396:319, 1996
4. Harder J, Bartels J, Christophers E, Schröder JM: A peptide antibiotic from human skin. Nature 387:861, 1997
5. Lehrer RI, Lichtenstein AK, Ganz T: Defensins: Antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol 11:105, 1993
6. Yamashita T, Saito K: Purification, primary structure, and biological activity of guinea pig neutrophil cationic peptides. Infect Immun 57:2405, 1989
7. Territo MC, Ganz T, Selsted ME, Lehrer RI: Monocyte chemotactic activity of defensins from human neutrophils. J Clin Invest 84:2017, 1989
8. Chertov O, Michiel DF, Xu L, Wang JM, Tani K, Murphy WJ, Longo DL, Taub DD, Oppenheim JJ: Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem 271:2935, 1997
9. Okrent DG, Lichtenstein AK, Ganz T: Direct cytotoxicity of polymorphonuclear leukocyte granule proteins to human lung-derived cells and endothelial cells. Am Rev Respir Dis 141:179, 1990
10. Panyutich AV, Szold O, Poon PH, Tseng Y, Ganz T: Identification of defensin binding to C1 complement. FEBS Lett 356:169, 1994
11. Panyutich AV, Ganz T: Activated alpha-2-macroglobulin is a principal defensin-binding protein. Am J Respir Cell Mol Biol 5:101, 1991
12. Panyutich AV, Hiemstra PS, van Wetering S, Ganz T: Human neutrophil defensin and serpins form complexes and inactivate each other. Am J Respir Cell Mol Biol 12:351, 1995
13. Prohaszka Z, Nemet K, Csermely P, Hudecz F, Mezo G, Fust G: Defensins purified from human granulocytes bind C1q and activate the classical complement pathway like the transmembrane glycoprotein gp41 of HIV-1. Mol Immunol 34:809, 1997
14. Ziccardi RJ, Cooper NR: Active disassembly of the first complement component, C1, by C1-inactivator. J Immunol 123:788, 1979
15. Ghebrehiwet B, Lim B-L, Peerschke EIB, Willis AC, Reid KBM: Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q. J Exp Med 179:1809, 1994
16. Eggleton P, Ghebrehiwet B, Sastry KN, Coburn J, Zaner KS, Reid KBM, Tauber AI: Identification of a gC1q-binding protein (gC1q-R) on the surface of human neutrophils. J Clin Invest 95:1569, 1995
17. Peerschke EIB, Ghebrehiwet B: Human blood platelets possess specific binding sites for C1q. J Immunol 138:1537, 1987
18. Malhotra R, Willis AC, Jensenius JC, Jackson J, Sim RB: Structure and homology of human C1q receptor (collectin receptor). Immunology 78:341, 1993
19. Eggleton P, Lieu TS, Zappi EG, Sastry K, Coburn J, Zaner KS, Sontheimer RD, Capra JD, Ghebrehiwet B, Tauber AI: Calreticulin is released from activated neutrophils and binds to C1q and Mannan-binding protein. Clin Immunol Immunopathol 72:405, 1994
20. Guan E, Robinson SL, Goodman EB, Tenner AJ: Cell-surface protein identified on phagocytic cells modulates the C1q-mediated enhancement of phagocytosis. J Immunol 152:4005, 1994
21. Ghebrehiwet B, Kew RR, Gruber BL, Marchese MJ, Peerschke EIB, Reid KBM: Murine mast cells express two types of C1q receptor that are involved in the induction of chemotaxis and chemokinesis. J Immunol 155:2614, 1995
22. Nepomuceno RR, Henschen-Edman AH, Burgess WH, Tenner AJ: cDNA cloning and primary structure analysis of C1qR(P), the human C1q/MBL/SPA receptor that mediates enhanced phagocytosis in vitro. Immunity 6:119, 1997
23. van den Berg RH, Faber-Krol MC, van Es LA, Daha MR: Regulation of the function of the first component of complement by human C1q receptor. Eur J Immunol 25:2206, 1995
24. van Wetering S, Mannesse-Lazeroms SP, Van Sterkenburg MA, Daha MR, Dijkman JH, Hiemstra PS: Effect of defensins on interleukin-8 synthesis in airway epithelial cells. Am J Physiol 272:L888, 1997
25. Wing MG, Seilly DJ, Bridgman DJ, Harrison RA: Rapid isolation and biochemical characterization of rat C1 and C1q. Mol Immunol 30:433, 1993
26. van den Dobbelsteen MEA, van der Woude FJ, Schroeijers WEM, Klar-Mohamad N, van Es LA, Daha MR: C1q, a subunit of the first component of complement, enhances the binding of aggregated IgG to rat renal mesangial cells. J Immunol 151:4315, 1993
27. Daha MR, van Es LA: Enhanced alternative pathway complement dependent degradation of soluble immunoglobulin aggregates by macrophages. Immunology 43:513, 1981
28. Mayer MM: Complement and complement fixation, in Kabat EA, Mayer MM (eds): Experimental Immunochemistry. Springfield, IL, Thomas, 1967, p 1914
29. Brandt J, Pippin J, Schulze M, Hänsch GM, Alpers CE, Johnson RJ, Gordon K, Couser WG: Role of the complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritis. Kidney Int 49:335, 1996
30. van den Dobbelsteen ME, Verhasselt V, Kaashoek JG, Timmerman JJ, Schroeijers WE, Venveij CL, van der Woude FJ, van Es LA, Daha MR: Regulation of C3 and factor H synthesis of human glomerular mesangial cells by IL-1 and interferon-gamma. Clin Exp Immunol 95:173, 1994
31. van den Berg RH, Faber-Krol MC, van de Klundert JAM, van Es LA, Daha MR: Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein. J Immunol 156:4466, 1996
32. Sim RB, Arlaud GJ, Colomb MG: C1 inhibitor-dependent dissociation of human complement component C1 bound to immune complexes. Biochem J 179:449, 1979
33. Panyutich AV, Panyutich EA, Krapivin VA, Baturevich EA, Ganz T: Plasma defensin concentrations are elevated in patients with sepsis or bacterial meningitis. J Lab Clin Med 122:202, 1993
34. Stove S, Welte T, Wagner TO, Kola A, Klos A, Bautsch W, Kohl J: Circulating complement proteins in patients with sepsis or systemic inflammatory response syndrome. Clin Diagn Lab Immunol 3:175, 1996
35. Macher AM, Bennett JE, Gadek JE, Frank MM: Complement depletion in cryptococcal sepsis. J Immunol 120:1686, 1978
36. Hosea SW, Brown EJ, Frank MM: The critical role of complement in experimental pneumococcal sepsis. J Infect Dis 142:903, 1980
37. Gardinali M, Padalino P, Vesconi S, Calcagno A, Ciappellano S, Conciato L, Chiara O, Agostoni A, Nespoli A: Complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis. Correlation with severity of disease. Arch Surg 127:1219, 1992
38. Sobajima J, Ozaki S, Osakada F, Uesugi H, Shirakawa H, Yoshida M, Nakao K: Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) in ulcerative colitis: Non-histone chromosomal proteins, HMG1 and HMG2. Clin Exp Immunol 107:135, 1997
39. Charles LA, Caldas MLR, Falk RJ, Terrell RS, Jennette JC: Antibodies against granule proteins activate neutrophils in vitro. J Leukoc Biol 50:539, 1991
40. Higazi AA-R, Barghouti II, Abu-Much R: Identification of an inhibitor of tissue-type plasminogen activator-mediated fibrinolysis in human neutrophils. J Biol Chem 270:9472, 1995
41. Higazi AA-R, Ganz T, Kariko K, Cines DB: Defensin modulates tissue-type plasminogen activator and plasminogen binding to fibrin and endothelial cells. J Biol Chem 271:17650, 1996